2013’s Most Notable Stories In “The Pink Sheet” DAILY
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA budget challenges, biosimilars, R&D revamps and social media are among stories from the past year that captured the attention of readers and reflect major biopharma trends.